Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements.
$125M sweet spot round size
1979
$125M
from 1 investors over 1 rounds
Surmodics, Inc. raised $125M on November 17, 2022
Investors: MidCap Financial